India's No.1 Weekly For The Pharmaceutical Industry
About us || Feedback|| Advertising || Subscribe || Archives 

Issue dated - 20th June 2002

Home > Corporate Monitor

Shantha gets WHO approval for Shanvac B vaccine
Shantha Biotechnics Private Ltd here, which was first to launch the indigenously developed hepatitis-B vaccine in the country, has secured the WHO certification for its product ‘Shanvac B’. Shantha is the only company in India to get this certification for hepatitis-B vaccine.

Herbicure to trial pain drug in US
AFTER the successful launch of Panekure a pain management drug that acts through a novel drug delivery system to protect the kidney and gastro-intestinal tract few weeks back in the domestic market, Kolkata based Herbicure Private Limited would be soon signing an agreement with a North American based organization for conducting clinical trials for its new product.

At A Glance

  
Inside Pharma

Pharma Pulse
Corporate Monitor
Happennings
Editorial
Scrips
Policies & Amend.
Bulk Drug Trends
Market Place
Product
Biotech
Conversation

Archives
Subscribe
Customer Service
Contact Us
Advertise
About Us

 Network Sites

  Express Computer

  IT People
  Network Magazine
  Business Traveller
  Hotelier & Caterer
  Travel & Tourism
  Exp. Backwaters
  Healthcare Mgmt.
  Express Textile
 Group Sites
  ExpressIndia
  Indian Express
  Financial Express

<Top of page>
ABOUT US FEEDBACK ADVERTISE SUBSCRIBE ARCHIVES
 


© Copyright 2000: Indian Express Group (Mumbai, India). All rights reserved throughout the world. This entire site is compiled in Mumbai by
The Business Publications Division of the Indian Express Group of Newspapers. Please contact our Webmaster for any queries on this site.